Coloplast As Stock Filter Stocks by Fundamentals
CLPBF Stock | USD 97.22 0.00 0.00% |
Fundamental analysis of Coloplast allows traders to better anticipate movements in Coloplast's stock price by examining its financial health and performance throughout various phases of its business cycle.
Coloplast |
Did you try this?
Run Sync Your Broker Now
Sync Your BrokerSync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. |
All Next | Launch Module |
Coloplast Fundamentals
Return On Equity | 0.75 | |||
Return On Asset | 0.17 | |||
Profit Margin | 0.20 % | |||
Operating Margin | 0.30 % | |||
Current Valuation | 28.84 B | |||
Shares Outstanding | 194.31 M | |||
Shares Owned By Insiders | 35.00 % | |||
Shares Owned By Institutions | 25.53 % | |||
Price To Earning | 37.47 X | |||
Price To Book | 22.60 X | |||
Price To Sales | 1.15 X | |||
Revenue | 22.58 B | |||
Gross Profit | 15.53 B | |||
EBITDA | 7.23 B | |||
Net Income | 4.71 B | |||
Cash And Equivalents | 854 M | |||
Cash Per Share | 4.02 X | |||
Total Debt | 16.36 B | |||
Debt To Equity | 2.83 % | |||
Current Ratio | 1.01 X | |||
Book Value Per Share | 27.81 X | |||
Cash Flow From Operations | 5.1 B | |||
Earnings Per Share | 3.14 X | |||
Price To Earnings To Growth | 3.41 X | |||
Target Price | 16.42 | |||
Number Of Employees | 14.5 K | |||
Beta | 0.21 | |||
Market Capitalization | 24.87 B | |||
Total Asset | 34.96 B | |||
Retained Earnings | 4.89 B | |||
Working Capital | 855 M | |||
Current Asset | 6.16 B | |||
Current Liabilities | 5.31 B | |||
Z Score | 0.6 | |||
Annual Yield | 0.02 % | |||
Five Year Return | 2.05 % | |||
Net Asset | 34.96 B | |||
Last Dividend Paid | 20.0 |
About Coloplast Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Coloplast AS's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Coloplast using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Coloplast AS based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
IGIB | iShares 5 10 Year | |
SPTL | SPDR Barclays Long | |
SCHH | Schwab REIT ETF | |
SPMB | SPDR Portfolio Mortgage | |
SPTI | SPDR Portfolio Intermediate |
Other Information on Investing in Coloplast Pink Sheet
Coloplast financial ratios help investors to determine whether Coloplast Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Coloplast with respect to the benefits of owning Coloplast security.